Management and Outcome of Left Ventricular Assist Device Infections in Patients Undergoing Cardiac Transplantation.
Zerelda Esquer GarrigosNatalia E Castillo AlmeidaPooja GurramPrakhar VijayvargiyaCristina G Corsini CampioliJohn M StulakStacey A RizzaLarry M BaddourM Rizwan SohailPublished in: Open forum infectious diseases (2020)
Patients with an LVAD-specific infection were treated with 2 weeks of pathogen-directed therapy postheart transplant without any relapses. For those without LVAD-specific infection or uncomplicated LVAD-related bacteremia who had completed antimicrobial therapy pretransplant, antibiotics were discontinued after standard perioperative prophylaxis and no relapses were observed.